PURLs

What BP target is appropriate for pregnant patients with mild chronic hypertension?

Author and Disclosure Information

 

References

CAVEATS

Patient characteristics and medication choices were limited

This trial does not identify a BP goal for patients who are at highest risk for complications of hypertension or who already have been given a diagnosis of a growth-restricted fetus, as those patients were excluded.

Most patients in the trial who required medications received labetalol or extended-­release nifedipine. It is unclear if other medications would produce similar outcomes.

CHALLENGES TO IMPLEMENTATION

Limited challenges anticipated

There should be limited challenges to implementation.

Pages

Copyright © 2023. The Family Physicians Inquiries Network. All rights reserved.

Online-Only Materials

AttachmentSize
PDF icon jfp07205183_methodology.pdf236.68 KB

Recommended Reading

The nation’s health secretary has this obstetrician on call
MDedge Family Medicine
Best practices document outlines genitourinary applications of lasers and energy-based devices
MDedge Family Medicine
Transcranial magnetic stimulation during pregnancy: An alternative to antidepressant treatment?
MDedge Family Medicine
Federal rules don’t require period product ingredients on packaging labels. States are stepping in.
MDedge Family Medicine
Adherence to cancer prevention guidance linked with reduced breast cancer recurrence, death risk
MDedge Family Medicine
Pausing endocrine therapy to attempt pregnancy is safe
MDedge Family Medicine
New USPSTF draft suggests mammography start at 40, not 50
MDedge Family Medicine
Risk assessment first urged for fragility fracture screening
MDedge Family Medicine
Early gestational diabetes treatment may improve neonatal outcomes
MDedge Family Medicine
BMI has greater impact on survival in younger breast cancer patients
MDedge Family Medicine